Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Kyverna Therapeutics Inc (NASDAQ: KYTX) was $5.41 for the day, down -8.15% from the previous closing price of $5.89. In other words, the price has decreased by -$8.15 from its previous closing price. On the day, 0.58 million shares were traded. KYTX stock price reached its highest trading level at $5.95 during the session, while it also had its lowest trading level at $5.3.
Ratios:
Our analysis of KYTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.39 and its Current Ratio is at 5.39. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.01.
On May 27, 2025, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $5.
On October 10, 2024, UBS started tracking the stock assigning a Buy rating and target price of $13.UBS initiated its Buy rating on October 10, 2024, with a $13 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KYTX now has a Market Capitalization of 254716960 and an Enterprise Value of 28200058.
Stock Price History:
The Beta on a monthly basis for KYTX is 3.74, which has changed by 0.19955659 over the last 52 weeks, in comparison to a change of 0.15927899 over the same period for the S&P500. Over the past 52 weeks, KYTX has reached a high of $7.20, while it has fallen to a 52-week low of $1.78. The 50-Day Moving Average of the stock is 25.95%, while the 200-Day Moving Average is calculated to be 66.40%.
Shares Statistics:
KYTX traded an average of 365.58K shares per day over the past three months and 390240 shares per day over the past ten days. A total of 43.24M shares are outstanding, with a floating share count of 21.32M. Insiders hold about 50.70% of the company’s shares, while institutions hold 25.38% stake in the company. Shares short for KYTX as of 1757894400 were 1608183 with a Short Ratio of 4.40, compared to 1755216000 on 1576692. Therefore, it implies a Short% of Shares Outstanding of 1608183 and a Short% of Float of 6.47.
Earnings Estimates
The company has 5.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.84, with high estimates of -$0.6 and low estimates of -$1.04.
Analysts are recommending an EPS of between -$3.35 and -$4.04 for the fiscal current year, implying an average EPS of -$3.71. EPS for the following year is -$3.43, with 5.0 analysts recommending between -$2.96 and -$4.21.
